BELLODI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 3.742
NA - Nord America 2.075
EU - Europa 1.375
SA - Sud America 1.156
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 8.409
Nazione #
US - Stati Uniti d'America 1.992
SG - Singapore 1.664
BR - Brasile 961
CN - Cina 944
SE - Svezia 695
HK - Hong Kong 557
VN - Vietnam 299
RU - Federazione Russa 228
DE - Germania 93
AR - Argentina 83
IE - Irlanda 72
IT - Italia 70
GB - Regno Unito 58
IN - India 55
CA - Canada 37
EC - Ecuador 37
FI - Finlandia 37
ID - Indonesia 36
BD - Bangladesh 28
FR - Francia 27
TR - Turchia 26
IQ - Iraq 25
JP - Giappone 24
MX - Messico 24
ZA - Sudafrica 24
CO - Colombia 23
AT - Austria 21
PK - Pakistan 20
PL - Polonia 19
PY - Paraguay 16
UA - Ucraina 14
VE - Venezuela 13
UZ - Uzbekistan 11
CL - Cile 10
UY - Uruguay 10
ES - Italia 9
IR - Iran 9
MA - Marocco 8
SA - Arabia Saudita 8
NL - Olanda 7
DO - Repubblica Dominicana 6
EG - Egitto 6
NP - Nepal 6
DZ - Algeria 5
XK - ???statistics.table.value.countryCode.XK??? 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
GR - Grecia 4
KR - Corea 4
BB - Barbados 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DK - Danimarca 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
RS - Serbia 3
TN - Tunisia 3
BG - Bulgaria 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GY - Guiana 1
IL - Israele 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
Totale 8.409
Città #
Singapore 625
Hong Kong 556
Dallas 555
Shanghai 299
Hefei 252
Lawrence 252
Princeton 249
Ashburn 223
Ho Chi Minh City 114
New York 86
São Paulo 77
Dublin 72
Moscow 71
Beijing 70
Hanoi 55
Los Angeles 45
The Dalles 31
Brasília 30
Helsinki 29
Rio de Janeiro 27
Belo Horizonte 26
Boardman 25
Pune 22
Brooklyn 21
Milan 21
Santa Clara 21
Washington 20
Columbus 18
Guangzhou 17
Guayaquil 17
Warsaw 17
Nuremberg 16
Haiphong 15
Houston 14
Curitiba 13
London 13
Chennai 12
Da Nang 12
Montreal 12
Orem 12
Porto Alegre 12
Stockholm 12
Buenos Aires 11
Denver 11
Suita 11
Tokyo 11
Biên Hòa 10
Boston 10
Guarulhos 10
Johannesburg 10
Salvador 10
Shenzhen 10
Ankara 9
Atlanta 9
Gainesville 9
Hải Dương 9
Karachi 9
San Francisco 9
Baghdad 8
Campinas 8
Manchester 8
Quito 8
Seattle 8
Tashkent 8
Tianjin 8
Vienna 8
Asunción 7
Changsha 7
Jakarta 7
Manaus 7
Montevideo 7
Sorocaba 7
Thái Bình 7
Canoas 6
Hortolândia 6
Joinville 6
Medellín 6
Ninh Bình 6
Recife 6
São Leopoldo 6
Toronto 6
Turku 6
Uberlândia 6
Araraquara 5
Bauru 5
Bogotá 5
Bragança Paulista 5
Cachoeiro de Itapemirim 5
Chicago 5
Conselheiro Lafaiete 5
Contagem 5
Dhaka 5
Erbil 5
Franca 5
Frankfurt am Main 5
Goiânia 5
Kassel 5
Limeira 5
Mexico City 5
Phoenix 5
Totale 4.502
Nome #
[F-18] FDG PET study in obsessive-compulsive disorder. A clinical metabolic correlation study after treatment 101
A FAMILY STUDY OF SCHIZOTYPAL DISORDER 91
A psychometric-genetic study of schizotypal disorder 88
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder 81
Abnormal pattern of cortical activation associated with voluntary movement in obsessive-compulsive disorder: An EEG study 76
5% CO2 challenge in healthy first degree relatives of patients with panic disorder 74
A psychosocial risk factor model for female eating disorders: A European multicentre project 74
AGE AT ONSET OF PANIC DISORDER - INFLUENCE OF FAMILIAL LIABILITY TO THE DISEASE AND OF CHILDHOOD SEPARATION ANXIETY DISORDER 73
35% CO2-65% O2 inhalation test in panic patients 71
A neuropsychological study of dissociation in cortical and subcortical functioning in Obsessive-Compulsive Disorder by Tower of Hanoi Task 71
A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge 71
A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study 70
A combined population and family-based study of eight European populations demonstrates association between BDNF and eating disorders. 68
Acoustic startle response in panic disorder 66
A neural network approach to the outcome definition on first treatment with sertraline in a psychiatric population 66
A new social-family model for eating disorders: A European multicentre project using a case–control design 66
Age at onset of panic disorder: influence of familial liability to the disease and of childhood separation anxiety disorder. American Journal of Psychiatry, 152: 1362-1364, 1995 62
A segregation study for panic disorder families in which probands are responsive to 35% CO2 challenge test. 61
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 61
Assessment of parent-of-origin effect in families unlineally affected with panic disorder-agoraphobia 53
Visuo-tactile shape perception in women with Anorexia Nervosa and healthy women with and without body concerns 53
A segregation study of panic disorder in families of panic patients responsive to the 35% CO2 challenge 50
Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis 50
Emotional Intelligence in Panic Disorder 48
Perceived vs. desired body size estimations in samples of anorectic and bulimic patients - MANUSCRIPT IN PREPARATION 48
Cross-disorder genome-wide analyses suggest a complex genetic relationship between tourette's syndrome and OCD 47
Obsessive compulsive disorder and mood disorders: A family study 46
Dizziness, migrainous vertigo and psychiatric disorders 42
Clinical predictors of drug response in obsessive-compulsive disorder 42
Assessment of parent-of-origin effect in families unilineally affected with Panic Disorder Agoraphobia. Journal of Psychiatric Research, 33: 37-39, 1999 42
EEG power modifications in obsessive-compulsive disorder during olfactory stimulation 42
Psychophysiological patterns of children at risk for panic disorder 42
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study 42
Histocompatibility antigens and effects of neuroactive drugs on phytohaemagglutinin stimulation of lymphocytes in vitro. 41
The structure of DSM-III-R schizotypal personality disorder diagnosed by direct interviews 41
Promoter polymorphisms of the 5HT2C receptor gene: Association study with panic disorder in two independent samples. 40
The Iowa Personality Disorder Screen: Development and preliminary validation of a brief screening interview 40
CARDIAC AUTONOMIC FUNCTION DURING SLEEP OF NEVER-DEPRESSED BORDERLINE SUBJECTS - A PILOT-STUDY 40
Common genetic, clinical; demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 39
Panic disorder: the role of the balance system 39
Morbidity Risk For Mood Disorders In The Families Of Borderline Patients 39
Carbon Dioxide/Oxygen Challenge Test in Panic Disorder. 39
Evaluation of mother-child agreement and factorial structures of the SCARED questionnaire in an Italian clinical sample 39
Sensitivity to 35% carbon dioxide in patients with generalized anxiety disorder 39
The unipolar-bipolar dichotomy and the response to sleep deprivation 39
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder 38
First-cycle REM density in never-depressed subjects with Borderline personality disorder. Biological Psychiatry 45: 1056-1058, 1999 38
COMT gene: Lessons from panic disorder for association studies in psychiatry 38
Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. 38
An assessment of the Wisconsin Card Sorting Test as an indicator of liability to schizophrenia. 38
An assessment of the Wisconsin Card Sorting Test as an indicator of liability to Schizophrenia. Schizophrenia Research, 14: 39-46, 1994 38
Proclactin secretion and response to stimuli in male heroin addicts. 37
Morbidity risk for obsessive-compulsive spectrum disorders in first-degree relatives of patients with eating disorders 37
Anticipation of age at onset in Panic Disorder. American Journal of Psychiatry,155 (5):590-595, 1998 37
Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study 37
Functional promoter polymorphism of the human serotonin transporter: Lack of association with panic disorder 37
Evaluating Proactive Strategy in Patients with OCD during Stop Signal Task 37
Familial risks and reproductive fitness in schizophrenia 36
Decision-making heterogeneity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes 36
Schizotypy in Partners of Patients with Schizotypal Personality Disorder 36
Obsessive-compulsive disorders in relatives of probands with anorexia nervosa. 36
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. 36
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 36
ICER promoter polymorphism - Association study in European panic samples 36
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study 35
Does the brain noradrenaline network mediate the effects of the CO2 challenge? 35
Fluvoxamine treatment and D-2 receptors: a pet study on OCD drug-naive patients 35
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: A single-blind study 35
Complex segregation analysis for obsessive compulsive disorder and related disorders 35
Temperament dimensions explain comorbidity of psychiatric disorders. Comprehensive Psychiatry, 37 (4): 292-298, 1996 35
Psychiatric disorders in the families of schizotypal subjects. Schizophrenia Bulletin,17 (4): 659-668, 1991 35
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. 35
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction 35
Analytic considerations about distribution of age of onset in schizophrenia. 35
The Co-Occurrence of DSM III-R Personality Disorders. 34
The calpain-calpastatin system in obsessive-compulsive disorder 34
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: An open study 34
Genetic variants of dopamine receptor D4 and psychopathology. 34
Cardiac autonomic function during sleep of never-depressed Borderline subjects: a pilot study. Journal of Psychiatric Research, 29: 397-405, 1995 34
Further study on N1-methylnicotinamide urinary output in patients with affective disorders. 34
Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study. 34
Genetic variants of dopamine receptor D4 and psychopathology 34
Genetics of obsessive-compulsive disorder spectrum: genetic models 34
Personality Features Related to Generalized Anxiety Disorder. 33
Executive Dysfunctions in Obsessive-Compulsive Patients and Unaffected Relatives: Searching for a New Intermediate Phenotype 33
Serotonergic modulation of the balance system in panic disorder: An open study 33
Cyclic alternating pattern of sleep electroencephalogram in patients with panic disorder 33
Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study 33
An investigation of the co-occurrence of panic and somatization disorders through temperamental variables 33
Possible linkage between primary affective disorder susceptibility locus and HLA haplotypes. 33
Manifesto for a European research network into obsessive-compulsive and related disorders 33
Respiratory irregularity in respiratory subtype panic 32
Psychoimmunoendocrine aspects of panic disorder. 32
Interference between anti-HLA antibodies and adrenergic receptor-binding drugs. 32
HYPERSENSITIVITY TO INHALATION OF CARBON-DIOXIDE AND PANIC ATTACKS 32
Further studies on the major histocompatibility complex as a genetic marker for schizophrenia. 32
Temperament dimensions explain the comorbidity of psychiatric disorders 32
COMORBIDITY OF PANIC AND SOMATIZATION DISORDER - A GENETIC-EPIDEMIOLOGIC APPROACH 32
Citalopram and panic disorder. 32
Vulnerability to 35% CO2 of panic disorder patients with a history of respiratory disorders 32
Totale 4.423
Categoria #
all - tutte 85.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 2 0 5 0 0 0
2021/202293 0 0 0 39 9 5 4 6 3 8 2 17
2022/20231.289 528 313 98 8 4 128 79 80 37 3 3 8
2023/2024454 10 8 38 52 30 128 15 35 5 14 15 104
2024/20252.631 379 62 24 62 46 232 278 183 558 436 201 170
2025/20263.941 606 684 777 1.382 460 32 0 0 0 0 0 0
Totale 8.433